{"id":451731,"date":"2021-03-05T08:33:31","date_gmt":"2021-03-05T13:33:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451731"},"modified":"2021-03-05T08:33:31","modified_gmt":"2021-03-05T13:33:31","slug":"cellectar-to-participate-at-upcoming-institutional-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/","title":{"rendered":"Cellectar to Participate at Upcoming Institutional Investor Conferences"},"content":{"rendered":"
\n

FLORHAM PARK, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc.\u00a0(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will be available for 1×1 meetings at the following upcoming conferences:<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n H.C. Wainwright Global Life Sciences Conference<\/strong>\n <\/td>\n<\/tr>\n
Date:<\/strong><\/td>\nMarch 9-10, 2021<\/td>\n<\/tr>\n
Time:<\/td>\nAvailable for 1×1 meetings<\/td>\n<\/tr>\n
\u00a0<\/td>\nTo schedule, click on the link HERE<\/a><\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Roth Capital Partners 33<\/strong>
\n
\n rd<\/strong>
\n <\/sup>
\n Annual Conference<\/strong>\n <\/td>\n<\/tr>\n
Date:<\/td>\nMarch 15-17, 2021<\/td>\n<\/tr>\n
Time:<\/td>\nAvailable for 1×1 meetings<\/td>\n<\/tr>\n
\u00a0<\/td>\nTo schedule, click on the link HERE<\/a><\/td>\n<\/tr>\n<\/table>\n

The company\u2019s presentation\u00a0is available for on-demand viewing in the link HERE<\/a>.<\/p>\n

\n About\u00a0Cellectar Biosciences, Inc.<\/strong>
\n
Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company\u2019s core objective is to leverage its proprietary Phospholipid Drug Conjugate\u2122 (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company\u2019s PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations.<\/p>\n

The company\u2019s product pipeline includes CLR 131, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope) directly to cancer cells, while limiting exposure to healthy cells unlike many traditional on-market treatment options. CLR 131, is currently being evaluated in the CLOVER-WaM Phase 2 pivotal study in patients with relapsed\/refractory (r\/r) Waldenstrom\u2019s macroglobulinemia, a Phase 2b study in r\/r multiple myeloma patients, the CLOVER-2 Phase 1 study for a variety of pediatric cancers, one preclinical PDC chemotherapeutic program (CLR 1900) and multiple partnered PDC assets.<\/p>\n

For more information, please visit www.cellectar.com<\/a> or join the conversation by liking and following us on the company\u2019s social media channels: Twitter<\/a>, LinkedIn<\/a>, and Facebook<\/a>.<\/p>\n

\n Contacts<\/strong>\n <\/p>\n

\n Investors:<\/strong>
\n
Monique Kosse
Managing Director
LifeSci Advisors
212-915-3820
monique@lifesciadvisors.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

FLORHAM PARK, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc.\u00a0(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will be available for 1×1 meetings at the following upcoming conferences: H.C. Wainwright Global Life Sciences Conference Date: March 9-10, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE \u00a0 \u00a0 Roth Capital Partners 33 rd Annual Conference Date: March 15-17, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE The company\u2019s presentation\u00a0is available for on-demand viewing in the link HERE. About\u00a0Cellectar Biosciences, Inc. Cellectar Biosciences is focused on the discovery, development and … <\/p>\n

Continue reading “Cellectar to Participate at Upcoming Institutional Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451731","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FLORHAM PARK, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc.\u00a0(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will be available for 1×1 meetings at the following upcoming conferences: H.C. Wainwright Global Life Sciences Conference Date: March 9-10, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE \u00a0 \u00a0 Roth Capital Partners 33 rd Annual Conference Date: March 15-17, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE The company\u2019s presentation\u00a0is available for on-demand viewing in the link HERE. About\u00a0Cellectar Biosciences, Inc. Cellectar Biosciences is focused on the discovery, development and … Continue reading "Cellectar to Participate at Upcoming Institutional Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T13:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cellectar to Participate at Upcoming Institutional Investor Conferences\",\"datePublished\":\"2021-03-05T13:33:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/\"},\"wordCount\":340,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/\",\"name\":\"Cellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==\",\"datePublished\":\"2021-03-05T13:33:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellectar to Participate at Upcoming Institutional Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Cellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk","og_description":"FLORHAM PARK, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc.\u00a0(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will be available for 1×1 meetings at the following upcoming conferences: H.C. Wainwright Global Life Sciences Conference Date: March 9-10, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE \u00a0 \u00a0 Roth Capital Partners 33 rd Annual Conference Date: March 15-17, 2021 Time: Available for 1×1 meetings \u00a0 To schedule, click on the link HERE The company\u2019s presentation\u00a0is available for on-demand viewing in the link HERE. About\u00a0Cellectar Biosciences, Inc. Cellectar Biosciences is focused on the discovery, development and … Continue reading \"Cellectar to Participate at Upcoming Institutional Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-05T13:33:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cellectar to Participate at Upcoming Institutional Investor Conferences","datePublished":"2021-03-05T13:33:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/"},"wordCount":340,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/","name":"Cellectar to Participate at Upcoming Institutional Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==","datePublished":"2021-03-05T13:33:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDkwNyM0MDQ4OTc1IzUwMDA2MzkzNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectar-to-participate-at-upcoming-institutional-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cellectar to Participate at Upcoming Institutional Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451731"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451731\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}